Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 18 min ago
Peer-reviewedCC BYMolecular genetics & genomic medicine

Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb-Girdle Muscular Dystrophy.

  1. 1Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
  2. 2Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  3. 3Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Background

Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α-dystroglycan, with variants in multiple genes, including CRPPA, which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb-girdle muscular dystrophy.Method

The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array-CGH was performed to confirm the copy number variant.Results

We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9-10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood-onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late-onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L).Conclusion

These findings expand the mutational and clinical spectrum of CRPPA-related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single-nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.

Related

  1. Insights into the Mechanism of Allele Conversion using a Fluorescent Reporter-Based Compound Heterozygous Allele Conversion Reporter (CHACR) Cell Line Model
    Murray Joss, Collins Emma, Lonetti Lisa +6
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  2. Phenotypic and molecular characterization of INPP5K-related congenital muscular dystrophy in four Egyptian patients
    Maha S. Zaki, Sherif F. Abdel-Ghafar, Karima Rafat +6
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  3. If Becker Muscular Dystrophy Initially Manifests with Heart Disease and Rhabdomyolysis, Neurological Work-up Is Imperative
    Josef Finsterer
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationJ-STAGE
  4. Planar covariation: a new key for the early detection of Duchenne muscular dystrophy walking behaviour
    Pablo Ruiz, Guy Cheron, Nicolas Deconinck +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  5. Non-invasive adjunctive diagnostic models incorporating high-frequency ultrasound and shear wave elastography for pediatric Duchenne muscular dystrophy
    Kun-Kun Qiang, Si-Ran Zhang, Hong Luo +1
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@article{alagha2026variable,
  title = {{Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb-Girdle Muscular Dystrophy.}},
  author = {Parnian Alagha and Fatemeh Ahangari and Ariana Kariminejad and Aida Ghasemi and Soheila Gholami and Neda Sadatian and Roxana Kariminejad and Kimia Kahrizi and Ali Asghar Okhovat and Hossein Najmabadi},
  journal = {Molecular genetics \& genomic medicine},
  year = {2026},
  month = oct,
  doi = {10.1002/mgg3.70312},
  url = {https://europepmc.org/article/MED/42910546},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb-Girdle Muscular Dystrophy.
AU  - Parnian Alagha
AU  - Fatemeh Ahangari
AU  - Ariana Kariminejad
AU  - Aida Ghasemi
AU  - Soheila Gholami
AU  - Neda Sadatian
AU  - Roxana Kariminejad
AU  - Kimia Kahrizi
AU  - Ali Asghar Okhovat
AU  - Hossein Najmabadi
PY  - 2026
DA  - 2026/10/01
JO  - Molecular genetics & genomic medicine
DO  - 10.1002/mgg3.70312
UR  - https://europepmc.org/article/MED/42910546
AB  - Background  Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α-dystroglycan, with variants in multiple genes, including CRPPA, which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb-girdle muscular dystrophy.Method  The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array-CGH was performed to confirm the copy number variant.Results  We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9-10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood-onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late-onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L).Conclusion  These findings expand the mutational and clinical spectrum of CRPPA-related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single-nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.
SN  - 2324-9269
ER  -